FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1899683031> ?p ?o ?g. }

• W1899683031 endingPage "2847" @default.
• W1899683031 startingPage "2847" @default.
• W1899683031 abstract "Efficacy of fimasartan/hydrochlorothiazide combination in hypertensive patients inadequately controlled by fimasartan monotherapy Moo-Yong Rhee,1 Sang Hong Baek,2 Weon Kim,3 Chang Gyu Park,4 Seung Woo Park,5 Byung-Hee Oh,6 Sang-Hyun Kim,7 Jae-Joong Kim,8 Joon-Han Shin,9 Byung-Su Yoo,10 Se-Joong Rim,11 Jong-Won Ha,12 Joon Hyung Doh,13 Youngkeun Ahn,14 Jei Keon Chae,15 Jeong Bae Park,16 Soon-Kil Kim,17 Cheol Ho Kim18 1Cardiovascular Center, Dongguk University Ilsan Hospital, Goyang, 2Catholic University of Korea, Seoul St Mary’s Hospital, Seoul, 3Cardiovascular Department of Internal Medicine, Kyung Hee University Medical Center, Seoul, 4Division of Cardiology, Guro Hospital, Korea University College of Medicine, Seoul, 5Division of Cardiology, Samsung Medical Center, Seoul, 6Department of Internal Medicine, Seoul National University Hospital, Seoul, 7Division of Cardiology, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, 8Division of Cardiology, Asan Medical Center, Seoul, 9Division of Cardiology, Ajou University Hospital, Suwon, 10Division of Cardiology, Wonju Severance Christian Hospital, Wonju, 11Division of Cardiology, GangNam Severance Hospital, Seoul, 12Division of Cardiology, Severance Hospital, Seoul, 13Division of Cardiology, Inje University Ilsan Hospital, Goyang, 14Department of Cardiology, Chonnam National University Hospital, Gwangju, 15Chonbuk National University Hospital, Jeonju, 16Department of Cardiology, Cheil General Hospital, Dankook University College of Medicine, Seoul, 17Department of Cardiology, Hanyang University Guri Hospital, Guri, 18Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea Background: The study reported here compared the blood pressure (BP)-lowering efficacy of fimasartan alone with that of fimasartan/hydrochlorothiazide (HCTZ) combination in patients whose BP goal was not achieved after 4 weeks of treatment with once-daily fimasartan 60 mg.Methods: Patients with sitting diastolic blood pressure (siDBP) ≥90 mmHg with 4 weeks of once-daily fimasartan 60 mg were randomly assigned to receive either once-daily fimasartan 60 mg/HCTZ 12.5 mg or fimasartan 60 mg for 4 weeks. After 4 weeks, the dose was increased from fimasartan 60 mg/HCTZ 12.5 mg to fimasartan 120 mg/HCTZ 12.5 mg or from fimasartan 60 mg to fimasartan 120 mg if siDBP was ≥90 mmHg.Results: Of the 263 randomized patients, 256 patients who had available efficacy data were analyzed. The fimasartan/HCTZ treatment group showed a greater reduction of siDBP compared to the fimasartan treatment group at Week 4 (6.88±8.10 mmHg vs 3.38±7.33, P=0.0008), and the effect persisted at Week 8 (8.67±9.39 mmHg vs 5.02±8.27 mmHg, P=0.0023). Reduction of sitting systolic BP in the fimasartan/HCTZ treatment group was also greater than that in the fimasartan treatment group (at Week 4, 10.50±13.76 mmHg vs 5.75±12.18 mmHg, P=0.0069 and, at Week 8, 13.45±15.15 mmHg vs 6.84±13.57 mmHg, P=0.0007). The proportion of patients who achieved a reduction of siDBP ≥10 mmHg from baseline and/or a mean siDBP <90 mmHg after 4 weeks of treatment was higher in the fimasartan/HCTZ treatment group than in the fimasartan treatment group (53.6% vs 39.8%, P=0.0359). The overall incidence of adverse drug reaction was 11.79% with no significant difference between the treatment groups.Conclusion: The combination treatment of fimasartan and HCTZ achieved better BP control than fimasartan monotherapy, and had comparable safety and tolerance to fimasartan monotherapy. Keywords: blood pressure, antihypertensive, angiotensin-converting enzyme inhibitor, angiotensin-receptor blocker, angiotensin II type 1 receptor, renin–angiotensin–aldosterone system inhibitor" @default.
• W1899683031 created "2016-06-24" @default.
• W1899683031 creator A5007620895 @default.
• W1899683031 creator A5012152027 @default.
• W1899683031 creator A5022253992 @default.
• W1899683031 creator A5025802408 @default.
• W1899683031 creator A5028094938 @default.
• W1899683031 creator A5036510943 @default.
• W1899683031 creator A5038699850 @default.
• W1899683031 creator A5040155349 @default.
• W1899683031 creator A5044738299 @default.
• W1899683031 creator A5052064676 @default.
• W1899683031 creator A5053631633 @default.
• W1899683031 creator A5058868268 @default.
• W1899683031 creator A5066644859 @default.
• W1899683031 creator A5067574162 @default.
• W1899683031 creator A5070000246 @default.
• W1899683031 creator A5075770656 @default.
• W1899683031 creator A5080532811 @default.
• W1899683031 creator A5086377751 @default.
• W1899683031 date "2015-06-01" @default.
• W1899683031 modified "2023-10-13" @default.
• W1899683031 title "Efficacy of fimasartan/hydrochlorothiazide combination in hypertensive patients inadequately controlled by fimasartan monotherapy" @default.
• W1899683031 cites W1497461844 @default.
• W1899683031 cites W1965317555 @default.
• W1899683031 cites W1965482421 @default.
• W1899683031 cites W1966190328 @default.
• W1899683031 cites W1974719260 @default.
• W1899683031 cites W1985259248 @default.
• W1899683031 cites W1992104685 @default.
• W1899683031 cites W1998267900 @default.
• W1899683031 cites W2017356020 @default.
• W1899683031 cites W2026110915 @default.
• W1899683031 cites W2036232808 @default.
• W1899683031 cites W2044296934 @default.
• W1899683031 cites W2049055087 @default.
• W1899683031 cites W2091694810 @default.
• W1899683031 cites W2092249899 @default.
• W1899683031 cites W2093462237 @default.
• W1899683031 cites W2095193332 @default.
• W1899683031 cites W2107967797 @default.
• W1899683031 cites W2124632742 @default.
• W1899683031 cites W2129991662 @default.
• W1899683031 cites W2135161259 @default.
• W1899683031 cites W2136177202 @default.
• W1899683031 cites W2136813842 @default.
• W1899683031 cites W2147152119 @default.
• W1899683031 cites W2171082420 @default.
• W1899683031 cites W2316135957 @default.
• W1899683031 cites W4230595223 @default.
• W1899683031 doi "https://doi.org/10.2147/dddt.s82098" @default.
• W1899683031 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4459623" @default.
• W1899683031 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26082615" @default.
• W1899683031 hasPublicationYear "2015" @default.
• W1899683031 type Work @default.
• W1899683031 sameAs 1899683031 @default.
• W1899683031 citedByCount "11" @default.
• W1899683031 countsByYear W18996830312016 @default.
• W1899683031 countsByYear W18996830312017 @default.
• W1899683031 countsByYear W18996830312018 @default.
• W1899683031 countsByYear W18996830312019 @default.
• W1899683031 countsByYear W18996830312020 @default.
• W1899683031 countsByYear W18996830312021 @default.
• W1899683031 countsByYear W18996830312022 @default.
• W1899683031 countsByYear W18996830312023 @default.
• W1899683031 crossrefType "journal-article" @default.
• W1899683031 hasAuthorship W1899683031A5007620895 @default.
• W1899683031 hasAuthorship W1899683031A5012152027 @default.
• W1899683031 hasAuthorship W1899683031A5022253992 @default.
• W1899683031 hasAuthorship W1899683031A5025802408 @default.
• W1899683031 hasAuthorship W1899683031A5028094938 @default.
• W1899683031 hasAuthorship W1899683031A5036510943 @default.
• W1899683031 hasAuthorship W1899683031A5038699850 @default.
• W1899683031 hasAuthorship W1899683031A5040155349 @default.
• W1899683031 hasAuthorship W1899683031A5044738299 @default.
• W1899683031 hasAuthorship W1899683031A5052064676 @default.
• W1899683031 hasAuthorship W1899683031A5053631633 @default.
• W1899683031 hasAuthorship W1899683031A5058868268 @default.
• W1899683031 hasAuthorship W1899683031A5066644859 @default.
• W1899683031 hasAuthorship W1899683031A5067574162 @default.
• W1899683031 hasAuthorship W1899683031A5070000246 @default.
• W1899683031 hasAuthorship W1899683031A5075770656 @default.
• W1899683031 hasAuthorship W1899683031A5080532811 @default.
• W1899683031 hasAuthorship W1899683031A5086377751 @default.
• W1899683031 hasBestOaLocation W18996830311 @default.
• W1899683031 hasConcept C126322002 @default.
• W1899683031 hasConcept C17744445 @default.
• W1899683031 hasConcept C199539241 @default.
• W1899683031 hasConcept C2781039245 @default.
• W1899683031 hasConcept C3017595490 @default.
• W1899683031 hasConcept C512399662 @default.
• W1899683031 hasConcept C71924100 @default.
• W1899683031 hasConceptScore W1899683031C126322002 @default.
• W1899683031 hasConceptScore W1899683031C17744445 @default.
• W1899683031 hasConceptScore W1899683031C199539241 @default.
• W1899683031 hasConceptScore W1899683031C2781039245 @default.
• W1899683031 hasConceptScore W1899683031C3017595490 @default.
• W1899683031 hasConceptScore W1899683031C512399662 @default.

• next